Related references
Note: Only part of the references are listed.Rapamycin Is a Potent Inhibitor of Skin Tumor Promotion by 12-O-Tetradecanoylphorbol-13-Acetate
L. Allyson Checkley et al.
CANCER PREVENTION RESEARCH (2011)
Cyclosporin A inhibits nucleotide excision repair via downregulation of the xeroderma pigmentosum group A and G proteins, which is mediated by calcineurin inhibition
Christiane Kuschal et al.
EXPERIMENTAL DERMATOLOGY (2011)
Cyclosporin A, but not everolimus, inhibits DNA repair mediated by calcineurin: implications for tumorigenesis under immunosuppression
Kai-Martin Thoms et al.
EXPERIMENTAL DERMATOLOGY (2011)
The mTOR Inhibitor Rapamycin Suppresses DNA Double-Strand Break Repair
Honghong Chen et al.
RADIATION RESEARCH (2011)
Expression of DNA mismatch repair proteins and MSH2 polymorphisms in nonmelanoma skin cancers of organ transplant recipients
C. M. Perrett et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Organ transplantation and skin cancer: basic problems and new perspectives
Guenther F. L. Hofbauer et al.
EXPERIMENTAL DERMATOLOGY (2010)
Cyclosporine A suppresses keratinocyte cell death through MPTP inhibition in a model for skin cancer in organ transplant recipients
Kimberly G. Norman et al.
MITOCHONDRION (2010)
Mechanisms of mutation formation with long-wave ultraviolet light (UVA)
Thomas M. Rünger et al.
PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE (2010)
Rapamycin Inhibits Yeast Nucleotide Excision Repair Independently of Tor Kinases
Melvin V. Limson et al.
TOXICOLOGICAL SCIENCES (2010)
Immune Effector Cells Produce Lethal DNA Damage in Cells Treated with a Thiopurine
Ilse Daehn et al.
CANCER RESEARCH (2009)
The role of the retinoblastoma/E2F1 tumor suppressor pathway in the lesion recognition step of nucleotide excision repair
Patrick S. Lin et al.
DNA REPAIR (2009)
Immunosuppressive Drugs in Kidney Transplantation Impact on Patient Survival, and Incidence of Cardiovascular Disease, Malignancy and Infection
Roberto Marcen
DRUGS (2009)
Checkpoint Kinase ATR Promotes Nucleotide Excision Repair of UV-induced DNA Damage via Physical Interaction with Xeroderma Pigmentosum Group A
Steven M. Shell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Significant response after treatment with the mTOR inhibitor sirolimus in combination with carboplatin and paclitaxel in metastatic melanoma patients
Friedegund Meier et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
PP2A regulates ionizing radiation-induced apoptosis through Ser46 phosphorylation of p53
Jun Mi et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Reactive oxygen species generated by thiopurine/UVA cause irreparable transcription-blocking DNA lesions
Reto Brem et al.
NUCLEIC ACIDS RESEARCH (2009)
Molecular concepts of virus infections causing skin cancer in organ transplant recipients
I. Nindl et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Skin cancer in organ transplant recipients -: Where do we stand today?
C. Ulrich et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
PTCH mutations in basal cell carcinomas from azathioprine-treated organ transplant recipients
C. A. Harwood et al.
BRITISH JOURNAL OF CANCER (2008)
More epidermal p53 patches adjacent to skin carcinomas in renal transplant recipients than in immunocompetent patients: the role of azathioprine
Ymke G. L. de Graaf et al.
EXPERIMENTAL DERMATOLOGY (2008)
Xeroderma pigmentosum group C gene expression is predominantly regulated by promoter hypermethylation and contributes to p53 mutation in lung cancers
Y-H Wu et al.
ONCOGENE (2007)
Use of proliferation signal inhibitors in non-melanoma skin cancer following renal transplantation
J. W. de Fijter
NEPHROLOGY DIALYSIS TRANSPLANTATION (2007)
Novel DNA lesions generated by the interaction between therapeutic thiopurines and UVA light
Xiaohong Zhang et al.
DNA REPAIR (2007)
Lessons learned from DNA repair defective syndromes
Kai-Martin Thoms et al.
EXPERIMENTAL DERMATOLOGY (2007)
Everolimus (RAD) inhibits in vivo growth of murine squamous cell carcinoma (SCC VII)
SS Khariwala et al.
LARYNGOSCOPE (2006)
Phosphorylation of nucleotide excision repair factor xeroderma pigmentosum group a by ataxia telangiectasia mutated and Rad3-related-dependent checkpoint pathway promotes cell survival in response to UV irradiation
XM Wu et al.
CANCER RESEARCH (2006)
A population-based study of skin cancer incidence and prevalence in renal transplant recipients
FJ Moloney et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
Nucleotide excision repair and cancer
Diana Leibeling et al.
JOURNAL OF MOLECULAR HISTOLOGY (2006)
Calcineurin inhibitors decrease DNA repair and apoptosis in human keratinocytes following ultraviolet B irradiation
DB Yarosh et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies
HM Kauffman et al.
TRANSPLANTATION (2005)
Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data
AC Webster et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Azathioprine and UVA light generate mutagenic oxidative DNA damage
P O'Donovan et al.
SCIENCE (2005)
Assessment of 3 xeroderma pigmentosum group C gene polymorphisms and risk of cutaneous melanoma:: a case-control study
S Blankenburg et al.
CARCINOGENESIS (2005)
The immunosuppressive drugs cyclosporin A and tacrolimus inhibit membrane depolarization-induced CREB transcriptional activity at the coactivator level
E Oetjen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Distinct inhibitory effects of tacrolimus and cyclosporin A on calcineurin phosphatase activity
M Fukudo et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Immunosuppressants and skin cancer in transplant patients: Focus on rapamycin
S Euvrard et al.
DERMATOLOGIC SURGERY (2004)
Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies
T Mathew et al.
CLINICAL TRANSPLANTATION (2004)
Phosphorylation of XPB helicase regulates TFIIH nucleotide excision repair activity
F Coin et al.
EMBO JOURNAL (2004)
Branches on the α-C atom of cyclosporin A residue 3 result in direct calcineurin inhibition and rapid cyclophilin 18 binding
YX Zhang et al.
CHEMBIOCHEM (2004)
Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation
M Guba et al.
TRANSPLANTATION (2004)
The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector
RA Screaton et al.
CELL (2004)
The TOR pathway: A target for cancer therapy
MA Bjornsti et al.
NATURE REVIEWS CANCER (2004)
Influence of immunosuppression on the prevalence of cancer after kidney transplantation
R Marcén et al.
TRANSPLANTATION PROCEEDINGS (2003)
The mammalian target of rapamycin (mTOR) partner, raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS) motif
H Nojima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Medical progress - Skin cancers after organ transplantation
S Euvrard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity
XF Wu et al.
CARCINOGENESIS (2003)
Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma
QY Wei et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
DNA repair in mononuclear cells: Role of serine/threonine phosphatases
M Herman et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2002)
p53 and DNA damage-inducible expression of the xeroderma pigmentosum group C gene
S Adimoolam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Cyclosporin-A suppresses p53-dependent repair DNA synthesis and apoptosis following ultraviolet-B irradiation
N Sugie et al.
PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE (2002)
p53 binds and activates the xeroderma pigmentosum DDB2 gene in humans but not mice
T Tan et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes
YW Qiao et al.
CARCINOGENESIS (2002)
Cross talk among calcineurin, Sp1/Sp3, and NFAT in control of p21WAF1/CIP1 expression in keratinocyte differentiation
MP Santini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
mTOR inhibitors: An overview
P Neuhaus et al.
LIVER TRANSPLANTATION (2001)
Genome maintenance mechanisms for preventing cancer
JHJ Hoeijmakers
NATURE (2001)
Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients
M Herman et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2001)
Reduced expression levels of nucleotide excision repair genes in lung cancer: a case-control analysis
L Cheng et al.
CARCINOGENESIS (2000)
Activation of p70 ribosomal protein S6 kinase is an essential step in the DNA damage-dependent signaling pathway responsible for the ultraviolet B-mediated increase in interstitial collagenase (MMP-1) and stromelysin-1 (MMP-3) protein levels in human dermal fibroblasts
P Brenneisen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
p53-dependent apoptosis in melanoma cells after treatment with camptothecin
G Li et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2000)
Share Paper
